Triangle Securities Wealth Management Eli Lilly & CO Transaction History

Triangle Securities Wealth Management

$377 Million
Q3 2024

A detailed history of Triangle Securities Wealth Management transactions in Eli Lilly & CO stock. As of the latest transaction made, Triangle Securities Wealth Management holds 3,882 shares of LLY stock, worth $3.09 Million. This represents 0.91% of its overall portfolio holdings.

Number of Shares

3,882

Previous 4,219 7.99%

Holding current value

$3.09 Million

Previous $3.82 Million 9.95%

% of portfolio

0.91%

Previous 1.1%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$772.14 - $960.02 $260,211 - $323,526	-337 Reduced 7.99%	3,882 $3.44 Million
Q2 2024 Jul 10, 2024	SELL	$724.87 - $909.04 $78,285 - $98,176	-108 Reduced 2.5%	4,219 $3.82 Million
Q1 2024 Apr 10, 2024	SELL	$592.2 - $792.28 $69,879 - $93,489	-118 Reduced 2.65%	4,327 $3.37 Million
Q4 2023 Jan 10, 2024	SELL	$525.19 - $619.13 $122,369 - $144,257	-233 Reduced 4.98%	4,445 $2.59 Million
Q3 2023 Oct 10, 2023	SELL	$434.7 - $599.3 $40,427 - $55,734	-93 Reduced 1.95%	4,678 $2.51 Million
Q2 2023 Jul 13, 2023	SELL	$350.74 - $468.98 $165,900 - $221,827	-473 Reduced 9.02%	4,771 $2.24 Million
Q1 2023 Apr 20, 2023	SELL	$310.63 - $364.82 $84,491 - $99,231	-272 Reduced 4.93%	5,244 $1.8 Million
Q4 2022 Jan 11, 2023	SELL	$321.55 - $374.67 $169,135 - $197,076	-526 Reduced 8.71%	5,516 $0
Q3 2022 Oct 19, 2022	SELL	$296.48 - $337.87 $156,837 - $178,733	-529 Reduced 8.05%	6,042 $1.95 Million
Q2 2022 Jul 11, 2022	SELL	$278.73 - $327.27 $158,318 - $185,889	-568 Reduced 7.96%	6,571 $2.13 Million
Q1 2022 Apr 13, 2022	SELL	$234.69 - $291.66 $241,730 - $300,409	-1,030 Reduced 12.61%	7,139 $2.04 Million
Q4 2021 Jan 14, 2022	SELL	$224.85 - $279.04 $73,975 - $91,804	-329 Reduced 3.87%	8,169 $2.26 Million
Q3 2021 Oct 14, 2021	SELL	$221.6 - $272.71 $108,805 - $133,900	-491 Reduced 5.46%	8,498 $1.96 Million
Q2 2021 Jul 12, 2021	SELL	$180.55 - $233.54 $16,610 - $21,485	-92 Reduced 1.01%	8,989 $2.06 Million
Q1 2021 Apr 12, 2021	SELL	$164.32 - $212.72 $37,793 - $48,925	-230 Reduced 2.47%	9,081 $1.7 Million
Q4 2020 Jan 11, 2021	SELL	$130.46 - $172.63 $1,304 - $1,726	-10 Reduced 0.11%	9,311 $1.57 Million
Q3 2020 Oct 09, 2020	SELL	$146.22 - $169.13 $55,417 - $64,100	-379 Reduced 3.91%	9,321 $1.38 Million
Q2 2020 Jul 08, 2020	SELL	$136.42 - $164.18 $230,004 - $276,807	-1,686 Reduced 14.81%	9,700 $1.59 Million
Q1 2020 Apr 06, 2020	SELL	$119.05 - $147.35 $86,906 - $107,565	-730 Reduced 6.03%	11,386 $1.58 Million
Q4 2019 Jan 09, 2020	SELL	$106.92 - $132.43 $40,522 - $50,190	-379 Reduced 3.03%	12,116 $1.59 Million
Q3 2019 Oct 15, 2019	SELL	$106.79 - $116.16 $5,339 - $5,808	-50 Reduced 0.4%	12,495 $1.4 Million
Q2 2019 Jul 10, 2019	SELL	$110.79 - $129.32 $37,557 - $43,839	-339 Reduced 2.63%	12,545 $1.4 Million
Q1 2019 Apr 08, 2019	SELL	$111.31 - $131.02 $178,875 - $210,549	-1,607 Reduced 11.09%	12,884 $1.67 Million
Q4 2018 Jan 17, 2019	SELL	$105.9 - $118.64 $9,425 - $10,558	-89 Reduced 0.61%	14,491 $1.68 Million
Q3 2018 Oct 04, 2018	SELL	$85.86 - $107.31 $4,722 - $5,902	-55 Reduced 0.38%	14,580 $1.57 Million
Q2 2018 Jul 12, 2018	SELL	$75.7 - $86.88 $20,741 - $23,805	-274 Reduced 1.84%	14,635 $1.25 Million
Q1 2018 Apr 11, 2018	BUY	$74.21 - $87.6 $94,617 - $111,690	1,275 Added 9.35%	14,909 $1.15 Million
Q4 2017 Jan 10, 2018	SELL	$81.94 - $87.89 $9,423 - $10,107	-115 Reduced 0.84%	13,634 $1.15 Million
Q3 2017 Oct 11, 2017	BUY	$77.07 - $85.54 $1.06 Million - $1.18 Million	13,749	13,749 $1.18 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $757B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Triangle Securities Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Triangle Securities Wealth Management with notifications on news.

Account

Triangle Securities Wealth Management Eli Lilly & CO Transaction History